| Challenges and strategies in thermal processing of amorphous solid dispersions: a review JS LaFountaine, JW McGinity, RO Williams Aaps Pharmscitech 17, 43-55, 2016 | 176 | 2016 |
| Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9 JS LaFountaine, K Fathe, HDC Smyth International journal of pharmaceutics 494 (1), 180-194, 2015 | 148 | 2015 |
| Thermal processing of PVP-and HPMC-based amorphous solid dispersions JS LaFountaine, LK Prasad, C Brough, DA Miller, JW McGinity, ... AAPS PharmSciTech 17, 120-132, 2016 | 85 | 2016 |
| Enabling thermal processing of ritonavir–polyvinyl alcohol amorphous solid dispersions by KinetiSol® dispersing JS LaFountaine, SV Jermain, LK Prasad, C Brough, DA Miller, D Lubda, ... European Journal of Pharmaceutics and Biopharmaceutics 101, 72-81, 2016 | 60 | 2016 |
| Formulation for oral administration of apoptosis promoter N Catron, MG Fickes, CM Fischer, R Gokhale, AR Haight, K Heemstra, ... US Patent App. 12/770,299, 2010 | 40 | 2010 |
| Formulation development-amorphous solid dispersions as enabling formulations for discovery and early development BE Padden, JM Miller, T Robbins, L Prasad, JK Spence, J LaFountaine American Pharmaceutical Review 14 (1), 66, 2011 | 39 | 2011 |
| Mucoadhesive amorphous solid dispersions for sustained release of poorly water soluble drugs JS LaFountaine, LK Prasad, DA Miller, JW McGinity, RO Williams III European Journal of Pharmaceutics and Biopharmaceutics 113, 157-167, 2017 | 33 | 2017 |
| Solid dispersions containing an apoptosis-promoting agent EA Schmitt, P Tong, K Heemstra, CM Fischer, H Wu, JM Miller, Y Li, ... US Patent App. 12/796,061, 2010 | 26 | 2010 |
| Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs JM Keen, JS LaFountaine, JR Hughey, DA Miller, JW McGinity AAPS PharmSciTech 19, 1998-2008, 2018 | 25 | 2018 |
| Solid dispersions containing kinase inhibitors JM Miller, R Gokhale, EA Schmitt, Y Gao, J Lafountaine, L Dias US Patent 8,557,995, 2013 | 24 | 2013 |
| Solid compositions B Liepold, T Jung, P Hölig, R Schroeder, NE Sever, JS Lafountaine, ... US Patent 8,686,026, 2014 | 18 | 2014 |
| Influence of process parameters on the preparation of pharmaceutical films by electrostatic powder deposition LK Prasad, JS LaFountaine, JM Keen, RO Williams III, JW McGinity International Journal of Pharmaceutics 515 (1-2), 94-103, 2016 | 13 | 2016 |
| Electrostatic powder deposition to prepare films for drug delivery LK Prasad, JM Keen, JS LaFountaine, J Maincent, RO Williams III, ... Journal of Drug Delivery Science and Technology 30, 501-510, 2015 | 12 | 2015 |
| Solid compositions B Liepold, T Jung, H Peter, R Schroeder, NE Sever, JS Lafountaine, ... US Patent App. 14/180,531, 2014 | 9 | 2014 |
| Solid compositions B Liepold, T Jung, P Holig, R Schroeder, NE Sever, J Lafountaine, ... | 7 | 2011 |
| Lipid-based formulations J LaFountaine, P Gao, RO Williams Formulating Poorly Water Soluble Drugs, 295-327, 2016 | 2 | 2016 |
| Processing and characterization of PVP-and HPMC-based amorphous solid dispersions: a comparison of hot melt extrusion and KinetiSol® Dispersing JS LaFountaine, LK Prasad, C Brough, K Ford, RO Williams III, J McGinity AAPS Annual Meeting, 2014 | 2 | 2014 |
| Čvrsti sastavi B Liepold, T Jung, P Holig, R Schroeder, NE Sever, J Lafountaine, ... | | 2019 |
| Solidinės kompozicijos B Liepold, T Jung, P Holig, R Schroeder, NE Sever, J Lafountaine, ... | | 2018 |
| Composiciones sólidas B Liepold, T Jung, P Holig, R Schroeder, NE Sever, J Lafountaine, ... | | 2018 |
